by Ken Lopez Founder & CEO A2L Consulting It has been said that management is either dead or dying. That is, when defined as the act of telling people what to do, management is needed far less than it used to be.
by Ken Lopez Founder & CEO A2L Consulting
by Ken Lopez Founder & CEO A2L Consulting The antitrust laws have been around for more than 100 years, and they have never been more relevant than they are today. Whether it’s a question of the interplay between patents and antitrust, a hospital merger, a high-tech acquisition, or an alleged conspiracy to fix prices, companies need to know how to defend themselves in antitrust cases. Often, they also need to know how to pursue such cases as a plaintiff as well.
by Ryan H. Flax (Former) Managing Director, Litigation Consulting A2L Consulting
by Theresa D. Villanueva, Esq. Director, Litigation Consulting A2L Consulting
by Ken Lopez Founder & CEO A2L Consulting
by Theresa Villanueva, Esq. Director, Litigation Consulting A2L Consulting
by Theresa D. Villanueva, Esq. Director, Litigation Consulting A2L Consulting
By Ryan H. Flax (Former) Managing Director, Litigation Consulting A2L Consulting
Forty-five states may have mandatory continuing legal education (CLE) requirements for attorneys – but all litigators and litigation support staff, wherever they are located, have a duty to stay informed and maintain their skills. Whether you are a first chair litigator or a litigation paralegal, given the pace of change in trial technology and trial strategy, it can be a challenge just to keep up with the latest trends.
This article is coauthored by A2L Consulting’s CEO, Kenneth J. Lopez, J.D., a trial graphics and trial consulting expert and David H. Schwartz, Ph.D. of Innovative Science Solutions. Dr. Schwartz has extensive experience designing programs that critically review the scientific foundation for product development and major mass tort litigation. For 20 years, he has worked with the legal community evaluating product safety and defending products such as welding rods, cellular telephones, breast implants, wound care products, dietary supplements, general healthcare products, chemical exposures (e.g., hydraulic fracturing components), and a host of pharmaceutical agents (including antidepressants, dermatologics, anti-malarials, anxiolytics, antipsychotics, and diet drugs).
Share: